CN114404523A - Composition for reducing blood sugar of human body due to diabetes, application and preparation method - Google Patents
Composition for reducing blood sugar of human body due to diabetes, application and preparation method Download PDFInfo
- Publication number
- CN114404523A CN114404523A CN202210057138.XA CN202210057138A CN114404523A CN 114404523 A CN114404523 A CN 114404523A CN 202210057138 A CN202210057138 A CN 202210057138A CN 114404523 A CN114404523 A CN 114404523A
- Authority
- CN
- China
- Prior art keywords
- composition
- charcoal
- raw materials
- diabetes
- chinese yew
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 239000008280 blood Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 42
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 45
- 239000003610 charcoal Substances 0.000 claims abstract description 40
- 239000003814 drug Substances 0.000 claims abstract description 34
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 claims abstract description 29
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000008671 Calycanthus floridus Nutrition 0.000 claims abstract description 14
- 235000008670 Calycanthus occidentalis Nutrition 0.000 claims abstract description 14
- 241001523681 Dendrobium Species 0.000 claims abstract description 14
- 244000148992 Lindera benzoin Species 0.000 claims abstract description 14
- 235000004520 Lindera benzoin Nutrition 0.000 claims abstract description 14
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 241000271897 Viperidae Species 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000004140 cleaning Methods 0.000 claims abstract description 8
- 239000006187 pill Substances 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000002674 ointment Substances 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 235000003499 redwood Nutrition 0.000 claims abstract description 4
- 240000005020 Acaciella glauca Species 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000271039 Agkistrodon Species 0.000 claims description 6
- 244000162450 Taxus cuspidata Species 0.000 claims description 5
- 235000009065 Taxus cuspidata Nutrition 0.000 claims description 5
- 238000010304 firing Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
- 241000282412 Homo Species 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 6
- 102000004877 Insulin Human genes 0.000 abstract description 3
- 108090001061 Insulin Proteins 0.000 abstract description 3
- 229940125396 insulin Drugs 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 11
- 229940079593 drug Drugs 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 4
- 235000017491 Bambusa tulda Nutrition 0.000 description 4
- 241001330002 Bambuseae Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 4
- 239000011425 bamboo Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241001505404 Deinagkistrodon acutus Species 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241001138418 Sequoia sempervirens Species 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 244000050510 Cunninghamia lanceolata Species 0.000 description 2
- 241001076416 Dendrobium tosaense Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000271042 Gloydius halys Species 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- YCXRBCHEOFVYEN-UHFFFAOYSA-N sciadopitysin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 YCXRBCHEOFVYEN-UHFFFAOYSA-N 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000272074 Bungarus Species 0.000 description 1
- 241000272079 Bungarus multicinctus Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000272060 Elapidae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical group OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241001116495 Taxaceae Species 0.000 description 1
- KOTXAHKUCAQPQA-MCBQMXOVSA-N Taxine A Chemical compound C1([C@@H]([C@@H](O)C(=O)O[C@@H]2C=3/C[C@@](C([C@H](O)C4=C(C)[C@@H](OC(C)=O)C[C@H](C4(C)C)[C@@H](OC(C)=O)\C=3)=O)(C)[C@@H](O)C2)N(C)C)=CC=CC=C1 KOTXAHKUCAQPQA-MCBQMXOVSA-N 0.000 description 1
- 241001116500 Taxus Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 241000545261 Xenocephalus Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229930189271 taxine Natural products 0.000 description 1
- KOTXAHKUCAQPQA-AAUVPWARSA-N taxine Chemical compound C1([C@@H]([C@@H](O)C(=O)O[C@@H]2C=3/C[C@@](C([C@H](O)C4=C(C)[C@@H](OC(C)=O)CC(C4(C)C)[C@@H](OC(C)=O)\C=3)=O)(C)[C@@H](O)C2)N(C)C)=CC=CC=C1 KOTXAHKUCAQPQA-AAUVPWARSA-N 0.000 description 1
- KOTXAHKUCAQPQA-NMDQKZLRSA-N taxine A Natural products O=C(O[C@@H]1/C/2=C\[C@@H](OC(=O)C)[C@H]3C(C)(C)C([C@H](O)C(=O)[C@](C)([C@H](O)C1)C\2)=C(C)[C@@H](OC(=O)C)C3)[C@H](O)[C@@H](N(C)C)c1ccccc1 KOTXAHKUCAQPQA-NMDQKZLRSA-N 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- VXQYICLHHMETFH-UHFFFAOYSA-N tetra-O-methylamentoflavone Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 VXQYICLHHMETFH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a composition for reducing blood sugar of a human body by diabetes, application and a preparation method thereof, wherein the composition comprises the following raw materials: carbonized human hair, Chinese yew charcoal, pseudo-ginseng charcoal, Chinese yew charcoal, combined spicebush leaf, musk, long-noded pit viper and dendrobium. Preferably comprising: 120g of carbonized human hair, 90g of carbonized redwood, 120g of carbonized pseudo-ginseng, 120g of carbonized Chinese yew, 20g of combined spicebush root leaves, 1g of musk, 30g of dendrobium and one piece of baked long-noded pit viper. The invention also provides the application of the composition, and the composition is used for preparing oral medicaments. The invention also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill. The composition provided by the invention is used in medicaments for various diabetes, and can reduce blood sugar and restore normal insulin function of a human body.
Description
Technical Field
The invention relates to a pharmaceutical composition, application and a preparation method thereof, in particular to a composition for reducing blood sugar of a human body by diabetes, application and a preparation method thereof.
Background
Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by a defect in insulin secretion or an impaired biological action, or both. Hyperglycemia occurring in the long term of diabetes results in chronic damage to, and dysfunction of, various tissues, particularly the eyes, kidneys, heart, blood vessels, nerves.
The clinical manifestations are mainly: 1. polydipsia, diuresis, polyphagia and emaciation. Severe hyperglycemia is typically characterized by "more than three and one less" symptoms, which are more common in type 1 diabetes. The symptoms of more than three and less than one are more obvious when ketosis or ketoacidosis occurs. 2. Fatigue, weakness and obesity. It is often seen in type 2 diabetes. Obesity usually occurs before type 2 diabetes, and if the diabetes cannot be diagnosed in time, the weight of the patient gradually decreases. Because the death of diabetes is hundreds of thousands of people every year, the new increase of diabetes is millions of people in the world.
At present, no method for radically treating diabetes exists, and the diabetes can only be controlled by various treatment means. The existing medicines for treating diabetes cannot completely cure symptoms, and also have the problems of long treatment period, unobvious effect and the like. Particularly, products which adopt components of Chinese herbal medicines, natural plants and the like do not exist in domestic and world markets at present, and the medicaments which can reduce blood sugar until diabetics recover are processed and produced.
Disclosure of Invention
The invention aims to provide a pharmaceutical composition, application and a preparation method thereof, the composition can solve the existing problems, is used for diabetes, can reduce blood sugar, and can recover the normal insulin function of a human body, thereby enabling a patient to recover.
In order to achieve the above object, the present invention provides a composition for reducing blood sugar of a human body due to diabetes, wherein the composition comprises the following raw materials: carbonized human hair, Chinese yew charcoal, pseudo-ginseng charcoal, Chinese yew charcoal, combined spicebush leaf, musk, long-noded pit viper and dendrobium.
The composition for reducing the blood sugar of the human body by the diabetes is characterized in that the raw materials are prepared by burning redwood charcoal; the notoginseng charcoal is prepared by firing notoginseng; the Chinese yew charcoal is prepared by burning taxus cuspidata; the herba Dendrobii is herba Dendrobii.
The composition for reducing blood sugar of a human body due to diabetes comprises the following raw materials in parts by weight: 100-150 parts of carbonized human blood, 80-100 parts of Chinese yew carbon, 100-150 parts of pseudo-ginseng carbon, 100-150 parts of Chinese yew carbon, 15-25 parts of combined spicebush leaves, 0.5-2 parts of musk and 20-40 parts of dendrobium.
The composition for reducing blood sugar of human body caused by diabetes comprises half or two pieces of baked long-noded pit viper.
The composition for reducing blood sugar of human body caused by diabetes comprises the following raw materials in parts by weight: 120g of carbonized human hair, 90g of Chinese yew charcoal, 120g of pseudo-ginseng charcoal, 120g of Chinese yew charcoal, 20g of combined spicebush root leaves, 1g of musk and 30g of dendrobium.
The composition for reducing blood sugar of human body caused by diabetes comprises one baked long-noded pit viper.
The invention also provides application of the composition for reducing blood sugar of a human body caused by diabetes, wherein the composition is used for preparing an internal medicament.
The invention also provides a preparation method of the medicament, wherein the method comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill.
The method for preparing the medicament, wherein the concentration multiple in the method is 50 times.
The preparation method of the medicament comprises the step of taking the medicament by warm boiled water every day, wherein 3g of the medicament is taken orally each time.
The composition for reducing the blood sugar of the human body in diabetes and the application and the preparation method thereof provided by the invention have the following advantages:
the invention utilizes the technologies of biological pharmacy and the like and high purification and extraction means, and the cooperation verification of the Chinese medical science college of the Chinese academy of sciences breaks through the prior art of treating and recovering diabetes, can effectively regulate the immunity and the endocrine balance of a human body, regulate and recover the normal insulin function of the human body, treat various types of diabetes and can reduce the blood sugar to the normal range value of the human body.
Detailed Description
The following further describes embodiments of the present invention.
The invention provides a composition for reducing blood sugar of a human body by diabetes, which comprises the following raw materials: carbonized human hair, Chinese yew charcoal, pseudo-ginseng charcoal, Chinese yew charcoal, combined spicebush leaf, musk, long-noded pit viper and dendrobium.
Wherein the carbonized human hair is carbonized substance. Taking hair, removing impurities, washing away oil dirt with alkaline water, rinsing with clear water, drying in the sun, calcining to form charcoal, and cooling. The product is in irregular block shape, black and bright, and has many pores. Light weight and crisp. The burnt herb turns into scorched smell and tastes bitter. Bitter in property and mild in taste. It enters liver and stomach meridians. Has effects of astringing, stopping bleeding, removing blood stasis, and promoting urination. Can be used for treating hematemesis, hemoptysis, epistaxis, stranguria with blood, hematuria, hematochezia, metrorrhagia, traumatic hemorrhage, and dysuria.
The Chinese fir charcoal is prepared by burning Chinese fir. The medicinal part of sequoia is trunk endothelium of sequoia sempervirens of Pinaceae. Distributed in Shaanxi, Gansu, Sichuan and Yunnan provinces. Taken off all the year round, scraped off the outer skin and dried in the sun. Pungent flavor and warm nature. It enters large intestine meridian. Has the effects of stopping dysentery and promoting qi circulation. It is commonly indicated for dysentery, rectocele, qi stagnation and abdominal distention.
The notoginseng charcoal is prepared by firing notoginseng. The medicinal part of Notoginseng radix is dried root of Notoginseng radix of Araliaceae. Digging before blooming in late summer and early autumn or after seeds are mature in winter, removing soil, cleaning, and drying in the sun. Unprocessed or ground into fine powder. Mainly contains saponin, flavonoid glycoside, amino acid, etc. The hemostatic active ingredient is dencichine. Sweet, slightly bitter and warm in nature and taste; it enters liver and stomach meridians. Has effects of removing blood stasis, stopping bleeding, promoting blood circulation, and relieving pain. It can be used for treating hemorrhage, traumatic injury, and swelling and pain due to blood stasis.
The yew charcoal is prepared by burning taxus cuspidata. The medicinal part of the taxus cuspidata is the leaves of the taxus cuspidata of the taxaceae family. Distributed in northeast China, Shandong, Jiangsu and Jiangxi. Picked all the year round, and fresh or dried in the sun for use. The leaf contains taxine, taxine A, volatile oil of sciadopitysin, sugar, etc. The bark of the stem contains paclitaxel. Bland taste and mild nature. Has the effects of inducing diuresis and relieving swelling. It is commonly used for nephritis, edema, dysuria and diabetes.
The folium Linderae Strychnifoliae is leaf of radix Linderae Strychnifoliae of Lauraceae. The radix linderae is distributed in Shaanxi, Anhui, Zhejiang, Jiangxi, Fujian, Taiwan, Hubei, Hunan, Guangxi, Sichuan and other places in China. Collected all the year round, cleaned, and used fresh or dried in the sun. Pungent flavor and warm nature. Enter spleen and kidney meridians. Has the effects of warming middle-jiao, regulating qi, relieving swelling and alleviating pain. It can be used for treating abdominal psychroalgia, frequent micturition, rheumatic arthralgia, traumatic injury, pain, and scald.
Moschus is secretion of the glandular sac of male animal of deer Moschus. The incense is taken 1 time in winter and spring every year, and is also taken 2 times in 3 and 4 months and 7 and 8 months every year. In the past, the male musk deer is hunted in winter and spring, and the musk sac is cut off from the belly skin and dried in the shade. The whole musk is obtained by cutting the hair short, which is also called feather incense. The musk particles in the capsule are dug and called musk kernel, which is also called dispersing fragrance. Pungent and warm in nature and flavor. Enter heart, spleen and liver meridians. The functions are as follows: inducing resuscitation, removing filth, dredging collaterals, and removing blood stasis. Can be used for treating apoplexy, phlegm syncope, epilepsy, vexation, heart and abdominal pain, abdominal mass, traumatic injury, carbuncle, cellulitis, and toxic swelling. Similar pharmacodynamic alternatives may also be employed, such as: artificial musk and the like.
The Agkistrodon acutus is whole body of Agkistrodon halys (Agkistrodon halys) of Agkistrodon family or Bungarus multicinctus of Elapidae family with viscera removed. The long bamboo poles and iron wires are generally used as a set of ropes for catching the five-step snakes in summer. After catching, cutting open abdomen and removing viscera, making the dish into a round shape, baking after opening with bamboo chips, or baking directly without opening with bamboo chips. Collectively referred to as big long-noded pit viper. Spreading and baking the dried product, also called Agkistrodon Gnathagnus; the one baked directly to dry is called Agkistrodon stick. Catching young Agkistrodon in summer, laparotomy, removing viscera, coiling into round shape, spreading with bamboo stick, and baking. It is called Bungarus Parvus. Sweet, salty, warm and toxic in nature. Enter liver and spleen meridians. Has the effects of dispelling pathogenic wind and removing dampness, penetrating into bones and muscles, and arresting convulsion. Can be used for treating rheumatism, paralysis, arthralgia, leprosy, scabies, tetany, tetanus, syphilitic sore, lymphoid tuberculosis, and malignant sore.
The herba Dendrobii is herba Dendrobii. The medicinal part of Dendrobium officinale Kimura et Migo is stem of Dendrobium officinale Kimura et Migo of Orchidaceae, which grows on tree and rock and is processed into maple bucket. Collected all the year round, preferably collected in late spring, early summer and autumn, steamed or baked to soft, and then dried in the sun or baked or fresh. Cold in nature, sweet, bland and slightly salty in flavor. The main functional indications are as follows: to nourish yin, clear heat, promote the production of body fluid and quench thirst. Can be used for treating febrile disease, impairment of body fluid, thirst, dryness of tongue, asthenia heat after illness, gastropathy, retching, and glossless tongue fur.
Preferably, the composition comprises the following raw materials in parts by weight: 100-150 parts of carbonized human blood, 80-100 parts of Chinese yew carbon, 100-150 parts of pseudo-ginseng carbon, 100-150 parts of Chinese yew carbon, 15-25 parts of combined spicebush leaves, 0.5-2 parts of musk and 20-40 parts of dendrobium.
The raw material also comprises half to two pieces of baked Agkistrodon acutus.
More preferably, the raw materials of the composition comprise by weight: 120g of carbonized human hair, 90g of Chinese yew charcoal, 120g of pseudo-ginseng charcoal, 120g of Chinese yew charcoal, 20g of combined spicebush root leaves, 1g of musk and 30g of dendrobium.
The raw material preferably also comprises one baked long-noded pit viper.
The raw materials are wild Chinese herbal medicines, and perennial Chinese herbal medicines are five years or more. The material is obtained from wild rare animals and plants, and can be artificially cultured and planted under the condition that conditions are not allowed, or other substitutes with equal and similar effects.
The invention also provides application of the composition for reducing blood sugar of a human body caused by diabetes, and the composition is used for preparing an oral medicament.
The invention also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill.
The concentration in this process was 50 times.
The auxiliary materials adopted are the common auxiliary materials used in the pharmaceutical technology and known by the technical personnel in the field.
Other specific conditions and equipment, etc. employed in the process are known to those skilled in the art.
The preparation is administered with warm boiled water every day, 3g per time.
The composition for reducing blood sugar of human body caused by diabetes, the use and the preparation method thereof provided by the invention are further described by combining the examples.
Example 1
A composition for reducing blood sugar of a human body caused by diabetes comprises the following raw materials in parts by weight: 120g of carbonized human hair, 90g of Chinese yew charcoal, 120g of pseudo-ginseng charcoal, 120g of Chinese yew charcoal, 20g of combined spicebush root leaves, 1g of musk and 30g of dendrobium.
The raw material also comprises one baked long-noded pit viper.
The embodiment also provides the application of the composition for reducing the blood sugar of the human body caused by diabetes, and the composition is used for preparing a medicament for internal administration.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill. The concentration factor is preferably 50 times.
The obtained preparation is administered with warm boiled water every day, 3g for each time.
Example 2
A composition for reducing blood sugar of a human body caused by diabetes comprises the following raw materials in parts by weight: 100g of carbonized human hair, 80g of Chinese yew charcoal, 100g of pseudo-ginseng charcoal, 100g of Chinese yew charcoal, 15g of combined spicebush root leaves, 0.5g of musk and 20g of dendrobium.
The raw material also comprises half baked Agkistrodon.
The embodiment also provides the application of the composition for reducing the blood sugar of the human body caused by diabetes, and the composition is used for preparing a medicament for internal administration.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill. The concentration factor is preferably 50 times.
The obtained preparation is administered with warm boiled water every day, 3g for each time.
Example 3
A composition for reducing blood sugar of a human body caused by diabetes comprises the following raw materials in parts by weight: 150g of carbonized human hair, 100g of Chinese yew charcoal, 150g of pseudo-ginseng charcoal, 150g of Chinese yew charcoal, 25g of combined spicebush root leaves, 2g of musk and 40g of dendrobium.
The raw material also comprises two pieces of baked Agkistrodon acutus.
The embodiment also provides the application of the composition for reducing the blood sugar of the human body caused by diabetes, and the composition is used for preparing a medicament for internal administration.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill. The concentration factor is preferably 50 times.
The obtained preparation is administered with warm boiled water every day, 3g for each time.
The raw materials adopted in the embodiments of the invention respectively accord with the corresponding national standards and regulations.
Clinical trials of the medicament prepared by the embodiments of the invention prove that the composition has obvious efficacy, and can effectively reduce the blood sugar to a normal range value of a human body aiming at various types of diabetes, thereby recovering the health of patients.
The invention provides a composition for reducing blood sugar of human body for diabetes, and application and a preparation method thereof. The composition also has the characteristics of reasonable formula, small using amount, obvious effect, small toxic and side effect, quick response and the like, and has the advantages of simple and easily obtained components, convenient processing, low price, high quality, economy, practicability and the like. The obtained preparation is also named as Liujia rui pill.
The invention is based on the differentiation of symptoms and signs of traditional Chinese medicine, aims at the etiology and pathogenesis of the disease, utilizes the compatibility principle that medicines supplement each other, purposefully and reasonably combines the medicines according to the organization structures of monarch, minister, assistant and guide, ensures that the medicines in the formula and the compatibility thereof are screwed with the pathogenesis of the disease, and highly unifies the comprehensive effect after the medicines are combined with the established treatment method.
While the present invention has been described in detail with reference to the preferred embodiments, it should be understood that the above description should not be taken as limiting the invention. Various modifications and alterations to this invention will become apparent to those skilled in the art upon reading the foregoing description. Accordingly, the scope of the invention should be determined from the following claims.
Claims (10)
1. A composition for reducing blood sugar in a human body due to diabetes, which is characterized by comprising the following raw materials: carbonized human hair, Chinese yew charcoal, pseudo-ginseng charcoal, Chinese yew charcoal, combined spicebush leaf, musk, long-noded pit viper and dendrobium.
2. The composition for lowering blood sugar of human body for diabetes according to claim 1, wherein in the raw materials, redwood charcoal is prepared by burning redwood; the notoginseng charcoal is prepared by firing notoginseng; the Chinese yew charcoal is prepared by burning taxus cuspidata; the herba Dendrobii is herba Dendrobii.
3. The composition for reducing blood sugar of a human body for diabetes according to claim 1, wherein the composition comprises the following raw materials in parts by weight: 100-150 parts of carbonized human blood, 80-100 parts of Chinese yew carbon, 100-150 parts of pseudo-ginseng carbon, 100-150 parts of Chinese yew carbon, 15-25 parts of combined spicebush leaves, 0.5-2 parts of musk and 20-40 parts of dendrobium.
4. The composition for lowering blood glucose in humans according to claim 3, wherein the raw material further comprises half to two pieces of baked Agkistrodon.
5. The composition for lowering blood glucose in humans according to claim 3, wherein the raw materials comprise by weight: 120g of carbonized human hair, 90g of Chinese yew charcoal, 120g of pseudo-ginseng charcoal, 120g of Chinese yew charcoal, 20g of combined spicebush root leaves, 1g of musk and 30g of dendrobium.
6. The composition for lowering blood glucose in humans according to claim 5, wherein the raw material further comprises a baked long-noded pit viper.
7. The use of the composition for lowering blood sugar of human body for diabetes according to any one of claims 1 to 6, wherein the composition is used for preparing a medicament for internal administration.
8. A method of preparing the medicament of claim 7, wherein the method comprises: weighing the raw materials in proportion, cleaning and drying the washable raw materials, grinding and crushing all the raw materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, adding auxiliary materials, and making into pill.
9. The method of claim 8, wherein the concentration is 50-fold.
10. The process for preparing a pharmaceutical preparation according to claim 8, wherein the preparation is administered orally with warm water 3g per day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210057138.XA CN114404523A (en) | 2022-01-19 | 2022-01-19 | Composition for reducing blood sugar of human body due to diabetes, application and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210057138.XA CN114404523A (en) | 2022-01-19 | 2022-01-19 | Composition for reducing blood sugar of human body due to diabetes, application and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114404523A true CN114404523A (en) | 2022-04-29 |
Family
ID=81274073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210057138.XA Pending CN114404523A (en) | 2022-01-19 | 2022-01-19 | Composition for reducing blood sugar of human body due to diabetes, application and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114404523A (en) |
-
2022
- 2022-01-19 CN CN202210057138.XA patent/CN114404523A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104187172B (en) | Functional feed for treating enterogastritis diseases of turtles and preparation method of functional feed | |
| CN105166544A (en) | Pig mixed feed and preparation method thereof | |
| CN104663975A (en) | Acanthopanax health tea for decreasing sugar and lipid and preparation method for acanthopanax health tea | |
| CN104383188A (en) | Pharmaceutical composition for preventing and treating piglet edema diseases and preparation method of pharmaceutical composition | |
| KR20090021644A (en) | A carbohydrate and lipid absorption inhibitory nelumbo composition and its manufacturing process thereof | |
| KR101456937B1 (en) | Composition comprising the extracts of natural material for controling or treating obesity | |
| CN112156113A (en) | Method for cultivating bezoar in ox gall by Chinese herbal medicine induction | |
| CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
| CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
| CN104288394A (en) | Traditional Chinese medicine composition for treating stroke and hemiplegia | |
| CN104189413A (en) | Medicine composition for treating enterogastritis diseases of turtles and preparation method of medicine composition | |
| CN103860977B (en) | A kind of pharmaceutical composition for the treatment of dermatitis | |
| CN114404523A (en) | Composition for reducing blood sugar of human body due to diabetes, application and preparation method | |
| CN104958474A (en) | Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof | |
| CN1861166A (en) | Medicinal composition for treating hyperinsulinar type polycystic overies and its prepn. method | |
| CN114344434B (en) | Traditional Chinese medicine composition for treating pulmonary nodules and preparation method thereof | |
| CN115554372B (en) | Traditional Chinese medicine for treating primary fibromyalgia syndrome and preparation method and application thereof | |
| CN108714167B (en) | A Chinese medicinal preparation for external use for treating vitiligo, and its preparation method | |
| CN115531471B (en) | Composition for resisting African swine fever as well as preparation method and application thereof | |
| CN114470104B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN111821361B (en) | Herbal liquid for relieving swelling, inflammation and pain, preparation method and application thereof | |
| CN108542965B (en) | Burdock root honey tablets and preparation method and application thereof | |
| CN117679457A (en) | Traditional Chinese medicine composition for preventing and treating chronic cheilitis as well as preparation method and application thereof | |
| CN107441387A (en) | A kind of Chinese medicinal formulae for being used to treat damp-heat constitution acne | |
| CN114344394A (en) | Pharmaceutical composition for reunion of bone and tendon and application and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220429 |
|
| RJ01 | Rejection of invention patent application after publication |